Natural Products Targeting on Oxidative Stress-Related Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 44100
Special Issue Editor
Interests: antioxidants; obesity; diabetes; cancer; oxidative stress; autophagy; cell signaling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic diseases, such as diabetes, obesity, inflammatory bowel disease, neurodegenerative diseases, cancer, and cardiovascular diseases, are the major risk factors for death and disability worldwide. Although the underlying mechanisms remain vague, accumulating evidence has reported that oxidative stress plays critical roles in the pathogenesis and development of these chronic diseases. Accordingly, oxidative stress-related signaling can be viewed as a potential therapeutic target for pharmaceutical intervention.
Recently, numerous studies have shown the spotlight on bioactivities of natural products against metabolic disorders of chronic diseases, since many non-natural, synthetic drugs cause various side effects. Naturally occurring compounds protect cells from redox imbalance as antioxidants, thus reducing risk of diabetes, obesity, and other oxidative stress-related diseases. However, a large number of these natural functional ingredients still remain unexploited, and a clear understanding of mechanisms of their benefit properties is awaiting further investigation.
We invite you to submit your latest research findings or a review article to this Special Issue, which will clarify the beneficial effects of natural compounds and demonstrate the mechanisms underlying their bioactivities using various disease models, including both in vitro and in vivo studies relating to any of the following topics: extraction and purification of natural functional ingredients and their application on oxidative damage caused by hazardous substances; beneficial properties of natural compounds on diabetes, obesity, fatty liver, cardiovascular disease, neurodegenerative diseases, aging, inflammation, cancer, and other oxidative stress-related diseases. Please note that in studies of complex mixtures of natural products, the characterization of chemicals using analytical methodologies, such as HPLC, MS, LC–MS and HPLC–MS, should be included.
Prof. Dr. Wei Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural compounds
- oxidative stress
- diabetes
- obesity
- inflammation
- cardiovascular diseases
- cancer
- neurodegenerative diseases
- aging
- fatty liver